Clinuvel Pharmaceuticals Limited ( CLVLY) - Key Metrics

CLVLY Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $0.72 $0.20 $0.25 $0.24
2025Q4 $1.19 $0.44 $0.56 $0.55
2025Q2 $0.71 $0.28 $0.26 $0.26
2024Q4 $1.10 $0.49 $0.21 $0.21
2024Q2 $0.64 $0.22 $0.53 $0.42

CLVLY Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 24.00% 15.12
2025Q4 0.00% 5.87
2025Q2 17.79% 11.11
2024Q4 0.06% 7.52
2024Q2 22.59% 18.45

CLVLY Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 1.91% 0.39%
2025Q4 5.35% 0.00%
2025Q2 2.09% 0.40%
2024Q4 1.40% 0.00%
2024Q2 2.59% 0.30%

CLVLY

Price: $6.95

52 week price:
5.95
9.00

Dividend Yield: 0.45%

5-year range yield:
0.06%
0.52%

Forward Dividend Yield: 0.52%

Payout Ratio: 7.24%

Payout Ratio Range:
0.00%
115.56%

Dividend Per Share: 0.04 USD

Earnings Per Share: 0.44 USD

P/E Ratio: 15.80

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Market Capitalization: 362.5 million

Average Dividend Frequency: 1

Years Paying Dividends: 9

DGR3: 7.22%

DGR5: 14.28%

Links: